Accelerated Approval of Cancer Drugs-Righting the Ship of the US Food and Drug Administration

被引：14
|
作者：
DiMagno, Sarah S. P. [1 ]
Glickman, Aaron [1 ]
Emanuel, Ezekiel J. [1 ,2 ]
机构：
[1] Univ Penn, Perelman Sch Med, Dept Med Eth & Hlth Policy, Philadelphia, PA 19104 USA
[2] Univ Penn, Wharton Sch, Dept Hlth Care Management, Philadelphia, PA 19104 USA
来源：
JAMA INTERNAL MEDICINE | 2019年 / 179卷 / 07期
关键词：
SURROGATE END-POINTS; ONCOLOGY; ASSOCIATION; SURVIVAL; STRENGTH;
D O I：
10.1001/jamainternmed.2019.0584
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：922 / 923
页数：2
相关论文
共 50 条
  • [1] Assessment of Coverage in England of Cancer Drugs Qualifying for US Food and Drug Administration Accelerated Approval
    Cherla, Avi
    Naci, Huseyin
    Kesselheim, Aaron S.
    Gyawali, Bishal
    Mossialos, Elias
    [J]. JAMA INTERNAL MEDICINE, 2021, 181 (04) : 490 - 498
  • [2] Exposure to US Cancer Drugs With Lack of Confirmed Benefit After US Food and Drug Administration Accelerated Approval
    Parikh, Ravi B. B.
    Hubbard, Rebecca A. A.
    Wang, Erkuan
    Royce, Trevor J. J.
    Cohen, Aaron B. B.
    Clark, Amy S. S.
    Mamtani, Ronac
    [J]. JAMA ONCOLOGY, 2023, 9 (04) : 567 - 569
  • [3] Recent Trends in Medicaid Spending and Use of Drugs With US Food and Drug Administration Accelerated Approval
    Sachs, Rachel E.
    Gavulic, Kyle A.
    Donohue, Julie M.
    Dusetzina, Stacie B.
    [J]. JAMA HEALTH FORUM, 2021, 2 (10): : E213177
  • [4] Characteristics of Preapproval and Postapproval Studies for Drugs Granted Accelerated Approval by the US Food and Drug Administration
    Naci, Huseyin
    Smalley, Katelyn R.
    Kesselheim, Aaron S.
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2017, 318 (07): : 626 - 636
  • [5] Oncologic Drugs Advisory Committee Recommendations and Approval of Cancer Drugs by the US Food and Drug Administration
    Tibau, Ariadna
    Ocana, Alberto
    Anguera, Georgia
    Seruga, Bostjan
    Templeton, Arnoud J.
    Barnadas, Agusti
    Amir, Eitan
    [J]. JAMA ONCOLOGY, 2016, 2 (06) : 744 - 750
  • [6] Food and Drug Administration approval process for ophthalmic drugs in the US
    Lloyd, Rhea
    Harris, Jennifer
    Wadhwa, Sonal
    Chambers, Wiley
    [J]. CURRENT OPINION IN OPHTHALMOLOGY, 2008, 19 (03) : 190 - 194
  • [7] US Food and Drug Administration Approval of Drugs for the Treatment of Prostate Cancer: A New Era Has Begun
    D'Amico, Anthony V.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (04) : 362 - 364
  • [8] US Food and Drug Administration Approval Overview in Metastatic Breast Cancer
    Cortazar, Patricia
    Justice, Robert
    Johnson, John
    Sridhara, Rajeshwari
    Keegan, Patricia
    Pazdur, Richard
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (14) : 1705 - 1711
  • [9] US Food and Drug Administration Accelerated Approval Program for Nononcology Drug Indications Between 1992 and 2018
    Omae, Kenji
    Onishi, Akira
    Sahker, Ethan
    Furukawa, Toshi A.
    [J]. JAMA NETWORK OPEN, 2022, 5 (09)
  • [10] Characteristics of Clinical Trials for the US Food and Drug Administration Accelerated Approval and Subsequent Confirmatory Trials: Implications for Drug Approval in Japan
    Mamiya, Hiroaki
    Narukawa, Mamoru
    [J]. BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2024, 47 (07) : 1345 - 1349
12345